| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 508.00▼ | 512.46▼ | 516.34▼ | 520.81▼ | 516.51▼ |
| MA10 | 510.07▼ | 519.20▼ | 525.07▼ | 508.54▼ | 514.65▼ |
| MA20 | 511.66▼ | 527.14▼ | 529.48▼ | 523.85▼ | 515.32▼ |
| MA50 | 518.66▼ | 526.20▼ | 519.47▼ | 517.84▼ | 498.16▲ |
| MA100 | 526.14▼ | 518.94▼ | 515.27▼ | 515.92▼ | 403.76▲ |
| MA200 | 530.26▼ | 517.39▼ | 528.94▼ | 510.92▼ | 312.12▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.135▼ | -2.941▼ | -3.884▼ | 0.058▲ | -2.756▼ |
| RSI | 25.065▼ | 21.098▼ | 29.844▼ | 45.765▼ | 50.662▲ |
| STOCH | 4.375▼ | 2.663▼ | 0.882▼ | 70.353 | 59.795 |
| WILL %R | -98.028▼ | -99.443▼ | -99.528▼ | -49.344 | -50.093 |
| CCI | -102.806▼ | -134.215▼ | -166.408▼ | 9.495 | 18.409 |
| RSI | $MDGL RSI(14) Crossed Below 50 | Set Alert |
| MA | $MDGL Price Crossed Below MA(200) | Set Alert |
| MA | $MDGL Price Crossed Below MA(50) | Set Alert |
| MA | $MDGL Price Crossed Below MA(26) | Set Alert |
| MA | $MDGL Price Crossed Below MA(13) | Set Alert |
| MA | $MDGL Price Crossed Below MA(7) | Set Alert |
| CDL | $MDGL Evening Star Candlestick Pattern Detected | Set Alert |
| CDL | $MDGL Engulfing Candlestick Pattern Detected | Set Alert |
| CDL | $MDGL Marubozu Candlestick Pattern Detected | Set Alert |
|
Wednesday, August 12, 2026 01:00 AM
CONSHOHOCKEN, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic ...
|
|
Thursday, August 06, 2026 09:05 AM
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...
|
|
Wednesday, August 05, 2026 01:56 AM
Madrigal Pharmaceuticals sustains strong commercial momentum with Rezdiffra, even amid new competition from semaglutide. Learn why MDGL stock is a hold.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/08/26 | 538.47 | 538.47 | 506.84 | 507.205 | 242,885 |
| 12/08/26 | 536.00 | 544.49 | 527.59 | 536.20 | 285,219 |
| 11/08/26 | 516.97 | 535.57 | 512.84 | 535.27 | 413,478 |
| 10/08/26 | 502.92 | 517.48 | 501.21 | 515.34 | 271,477 |
| 07/08/26 | 511.97 | 517.26 | 502.8425 | 510.04 | 347,529 |
| 06/08/26 | 513.32 | 524.45 | 509.00 | 510.36 | 288,860 |
| 05/08/26 | 510.88 | 516.25 | 503.645 | 514.12 | 327,345 |
| 04/08/26 | 492.73 | 513.76 | 489.795 | 507.56 | 403,906 |
| 03/08/26 | 462.15 | 485.9499 | 461.26 | 482.00 | 463,895 |
| 31/07/26 | 486.26 | 487.725 | 460.11 | 467.32 | 794,640 |
|
|
||||
|
|
||||
|
|